The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer
There has been a rapid expansion of immunotherapy options for non-small cell lung cancer (NSCLC) over the past two decades, particularly with the advent of immune checkpoint inhibitors. Despite the emerging role of immunotherapy in adjuvant and neoadjuvant settings though, relatively few patients wi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Open Exploration Publishing Inc.,
2024-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|